A Phase I Trial of Weekly Indenoisoquinoline LMP400 in Adults With Relapsed Solid Tumors and Lymphomas
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Indotecan (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 20 May 2016 Status changed from active, no longer recruiting to completed.
- 11 May 2015 Status changed from recruiting to active, no longer recruiting , according to ClinicalTrials.gov record.